Melanotan II: Daily subcutaneous injections during loading phase (48 weeks), then 23 weekly maintenance for pigmentation and related effects [5]
Summary: Tirzepatide shows the greatest weight loss, semaglutide 2.4 mg has the strongest long-term safety and cardiovascular evidence, and liraglutide offers a well-studied daily option
The key application remains diabetes and obesity treatment, with future opportunities in expanding indications such as cardiovascular health
Serum GLP-1 levels showed direct proportionality with several metabolic risk markers (that is, body mass index (BMI), leptin, insulin) over 109 men diagnosed with schizophrenia and on clozapine, while this association was not observed in women 131
Individual results vary based on dose, lifestyle modifications, and starting metabolic health
Others argue for more beef, more butter, more fiber, or stricter discipline